Fairvalue-Calculator Fairvalue-Calculator
EN DE

A-SPINE Asia Co (6758) Fair Value & Analysis

Healthcare · TW · Market cap 404M TWD

Price30.00 TWD
Fair Value22.39 TWD
Upside-25.4%
Quality95/100
Evidence: High Range 16.79 TWD – 27.99 TWD

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

A-SPINE Asia Co (6758) currently trades at 30.00 TWD, while our model-based Fair Value estimate is 22.39 TWD — implying the stock looks roughly 25.4% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

A-SPINE Asia Co., Ltd., a medical device company, engages in the research, development, manufacture, and marketing of spinal implants and instruments in Taiwan, China, the Philippines, Australia, New Zealand, Iran, Vietnam, Indonesia, Spain, Trinidad, and Sri Lanka. The company offers spinal fixation systems, such as cervical anterior fixation, and thoracic and lumbar fixation systems; interbody fixation systems, including ACDF cages, PLIF/TLIF cages, and ALIF cages; balloon kyphoplasty products; and vertebral body replacement products. It sells imported orthopedic medical devices. A-SPINE Asia Co., Ltd.was founded in 2001 and is based in New Taipei City, Taiwan.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is A-SPINE Asia Co (6758) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 22.39 TWD versus a price of 30.00 TWD — about −25% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 6758?
Our 21-model fair value for A-SPINE Asia Co is 22.39 TWD (as of Jun 24, 2026), built from audited fundamentals. The current price is 30.00 TWD.
What is the quality score of 6758?
A-SPINE Asia Co has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.